Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma

NCT00335764 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

92

Enrollment

NIH

Sponsor class

Conditions

Adult Giant Cell Glioblastoma
Adult Glioblastoma
Adult Gliosarcoma
Recurrent Adult Brain Tumor

Interventions

DRUG: sorafenib tosylate
DRUG: erlotinib hydrochloride
DRUG: tipifarnib
DRUG: temsirolimus

Sponsor

National Cancer Institute (NCI)